2015
Effects of suvorexant, an orexin receptor antagonist, on breathing during sleep in patients with chronic obstructive pulmonary disease
Sun H, Palcza J, Rosenberg R, Kryger M, Siringhaus T, Rowe J, Lines C, Wagner JA, Troyer MD. Effects of suvorexant, an orexin receptor antagonist, on breathing during sleep in patients with chronic obstructive pulmonary disease. Respiratory Medicine 2015, 109: 416-426. PMID: 25661282, DOI: 10.1016/j.rmed.2014.12.010.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAzepinesCross-Over StudiesDouble-Blind MethodFemaleHumansMaleMiddle AgedOrexin Receptor AntagonistsPulmonary Disease, Chronic ObstructiveRespirationSeverity of Illness IndexSleepSleep Aids, PharmaceuticalSpirometryTreatment OutcomeTriazolesUnited StatesConceptsChronic obstructive pulmonary diseaseObstructive pulmonary diseaseSleep breathing disordersOrexin receptor antagonistPulmonary diseaseBreathing disordersReceptor antagonistModerate chronic obstructive pulmonary diseaseDay 4Effects of suvorexantModerate airflow limitationRespiratory depressant effectsApnea-hypopnea indexMaximum daily doseClinical research unitTotal sleep timeTreatment of insomniaMean AHICOPD patientsAirflow limitationHypopnea indexDaily doseMean SpO2Spirometry criteriaHypnotic medications
1986
Alteration in Breathing Pattern with Progression of Chronic Obstructive Pulmonary Disease1,2
Loveridge B, West P, Kryger M, Anthonisen N. Alteration in Breathing Pattern with Progression of Chronic Obstructive Pulmonary Disease1,2. American Journal Of Respiratory And Critical Care Medicine 1986, 134: 930-934. PMID: 3777689, DOI: 10.1164/arrd.1986.134.5.930.Peer-Reviewed Original ResearchMeSH KeywordsForced Expiratory VolumeHumansLung Diseases, ObstructiveRespirationSpirometryTidal VolumeTime FactorsConceptsChronic obstructive pulmonary diseaseRespiratory failureSevere groupBreathing patternRespiratory inductance plethysmographStable chronic obstructive pulmonary diseaseRespiratory failure groupChronic obstructive pulmonaryObstructive pulmonary diseaseSignificant decreaseVT/TISeverity of diseasePulmonary diseaseAcute reliefFailure groupSupplemental O2Minute ventilationVentilatory controlTidal volumeModerate groupMechanical abnormalitiesInductance plethysmographBreathing frequencySeated positionFEV1
1981
Upper Airway Obstruction
Acres J, Kryger M. Upper Airway Obstruction. CHEST Journal 1981, 80: 207-211. PMID: 7249767, DOI: 10.1378/chest.80.2.207.Peer-Reviewed Original Research
1978
Excessive Polycythemia of High Altitude: Role of Ventilatory Drive and Lung Disease1–3
Kryger M, McCullough R, Doekel R, Collins D, Weil J, Grover R. Excessive Polycythemia of High Altitude: Role of Ventilatory Drive and Lung Disease1–3. American Journal Of Respiratory And Critical Care Medicine 1978, 118: 659-666. PMID: 707889, DOI: 10.1164/arrd.1978.118.4.659.Peer-Reviewed Original ResearchConceptsCause of hypoxemiaExcessive polycythemiaPolycythemic patientsTidal volumeNormal subjectsExcessive hypoxemiaChemical driveAbnormal breathing patternsAlveolar-arterial differenceSmall tidal volumesHigh-altitude residentsRespiratory QuestionnaireSpirometric featuresHypoxic depressionVentilatory driveLung diseaseControl subjectsVentilatory responseMinute ventilationNormal lungBreathing patternHypoxemiaPatientsPolycythemiaDead space
1974
Effect of gas density and expiratory flow on "closing volume".
Kryger M, Martin R, Macklem P, Anthonisen N. Effect of gas density and expiratory flow on "closing volume". Journal Of Applied Physiology 1974, 37: 831-834. PMID: 4436215, DOI: 10.1152/jappl.1974.37.6.831.Peer-Reviewed Original Research
1972
Gas diffusion across collateral channels.
Hogg W, Brunton J, Kryger M, Brown R, Macklem P. Gas diffusion across collateral channels. Journal Of Applied Physiology 1972, 33: 568-575. PMID: 4635918, DOI: 10.1152/jappl.1972.33.5.568.Peer-Reviewed Original Research